144 related articles for article (PubMed ID: 1670959)
21. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder.
Montone KT; Friedman H; Hodinka RL; Hicks DG; Kant JA; Tomaszewski JE
Mod Pathol; 1992 May; 5(3):292-302. PubMed ID: 1323104
[TBL] [Abstract][Full Text] [Related]
22. Lymphoproliferative disease after allogeneic stem cell transplantation--pre-emptive diagnosis by quantification of Epstein-Barr virus DNA in serum.
Aalto SM; Juvonen E; Tarkkanen J; Volin L; Ruutu T; Mattila PS; Piiparinen H; Knuutila S; Hedman K
J Clin Virol; 2003 Dec; 28(3):275-83. PubMed ID: 14522066
[TBL] [Abstract][Full Text] [Related]
23. Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders.
Limaye AP; Huang ML; Atienza EE; Ferrenberg JM; Corey L
J Clin Microbiol; 1999 Apr; 37(4):1113-6. PubMed ID: 10074534
[TBL] [Abstract][Full Text] [Related]
24. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.
Preiksaitis JK; Diaz-Mitoma F; Mirzayans F; Roberts S; Tyrrell DL
J Infect Dis; 1992 Nov; 166(5):986-94. PubMed ID: 1328412
[TBL] [Abstract][Full Text] [Related]
25. Lymphoid interstitial pneumonia not associated with HIV infection: role of Epstein-Barr virus.
Malamou-Mitsi V; Tsai MM; Gal AA; Koss MN; O'Leary TJ
Mod Pathol; 1992 Sep; 5(5):487-91. PubMed ID: 1344810
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients.
Strazzabosco M; Corneo B; Iemmolo RM; Menin C; Gerunda G; Bonaldi L; Merenda R; Neri D; Poletti A; Montagna M; Del Mistro A; Faccioli AM; D'Andrea E
J Hepatol; 1997 Apr; 26(4):926-34. PubMed ID: 9126809
[TBL] [Abstract][Full Text] [Related]
27. Active Epstein-Barr virus infection after allogeneic stem cell transplantation: re-infection or reactivation?
Meijer E; Spijkers S; Moschatsis S; Boland GJ; Thijsen SF; van Loon AM; Verdonck LF
Transpl Infect Dis; 2005 Mar; 7(1):4-10. PubMed ID: 15984942
[TBL] [Abstract][Full Text] [Related]
28. [Significance of Epstein-Barr virus DNA quantitation in donors of hematopoietic stem cell transplantation].
Jung S; Lim J; Cho BS; Chae H; Kim M; Kim Y; Han K; Lee JW; Min WS
Korean J Lab Med; 2010 Dec; 30(6):554-8. PubMed ID: 21157138
[TBL] [Abstract][Full Text] [Related]
29. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070
[TBL] [Abstract][Full Text] [Related]
30. Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction.
Wagner HJ; Bein G; Bitsch A; Kirchner H
J Clin Microbiol; 1992 Nov; 30(11):2826-9. PubMed ID: 1333480
[TBL] [Abstract][Full Text] [Related]
31. Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens.
Ambinder RF; Lambe BC; Mann RB; Hayward SD; Zehnbauer BA; Burns WS; Charache P
Mol Cell Probes; 1990 Oct; 4(5):397-407. PubMed ID: 2177846
[TBL] [Abstract][Full Text] [Related]
32. Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers.
Kaplan MA; Ferry JA; Harris NL; Jacobson JO
Am J Clin Pathol; 1994 May; 101(5):590-6. PubMed ID: 8178765
[TBL] [Abstract][Full Text] [Related]
33. B-cell lymphoproliferative disorders in solid-organ transplant patients: detection of Epstein-Barr virus by in situ hybridization.
Berg LC; Copenhaver CM; Morrison VA; Gruber SA; Dunn DL; Gajl-Peczalska K; Strickler JG
Hum Pathol; 1992 Feb; 23(2):159-63. PubMed ID: 1310951
[TBL] [Abstract][Full Text] [Related]
34. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.
Colombini E; Guzzo I; Morolli F; Longo G; Russo C; Lombardi A; Merli P; Barzon L; Murer L; Piga S; Ciofi Degli Atti ML; Locatelli F; Dello Strologo L
Pediatr Nephrol; 2017 Aug; 32(8):1433-1442. PubMed ID: 28280938
[TBL] [Abstract][Full Text] [Related]
35. Heart allograft involvement with Epstein-Barr virus-associated posttransplant lymphoproliferative disorder.
Abu-Farsakh H; Cagle PT; Buffone GJ; Bruner JM; Weilbaecher D; Greenberg SD
Arch Pathol Lab Med; 1992 Jan; 116(1):93-5. PubMed ID: 1310382
[TBL] [Abstract][Full Text] [Related]
36. Valganciclovir administration to kidney donors to reduce the burden of cytomegalovirus and Epstein-Barr virus transmission during transplantation.
Verghese PS; Schmeling DO; Knight JA; Matas AJ; Balfour HH
Transplantation; 2015 Jun; 99(6):1186-91. PubMed ID: 25489844
[TBL] [Abstract][Full Text] [Related]
37. Molecular epidemiology of Epstein-Barr virus infection.
Gratama JW; Ernberg I
Adv Cancer Res; 1995; 67():197-255. PubMed ID: 8571815
[No Abstract] [Full Text] [Related]
38. Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction.
Wagner HJ; Wessel M; Jabs W; Smets F; Fischer L; Offner G; Bucsky P
Transplantation; 2001 Sep; 72(6):1012-9. PubMed ID: 11579293
[TBL] [Abstract][Full Text] [Related]
39. Comparison of immortalization assay and polymerase chain reaction detection of Epstein-Barr virus in pediatric transplant recipients and control samples.
Salimi B; Alonso EM; Cohn RA; Mendley SR; Katz BZ
Pediatr Pathol Mol Med; 2002; 21(4):433-43. PubMed ID: 12092707
[TBL] [Abstract][Full Text] [Related]
40. Development of a real-time quantitative assay for detection of Epstein-Barr virus.
Niesters HG; van Esser J; Fries E; Wolthers KC; Cornelissen J; Osterhaus AD
J Clin Microbiol; 2000 Feb; 38(2):712-5. PubMed ID: 10655372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
